empty
 
 
sk
Search
Podpora
Okamžité otvorenie účtu
Obchodná platforma
Vklad / odobratie
Search
Pre začiatočníkov Pre obchodníkov Pre partnerov Dajte si pauzu O InstaForexe
sk
#ALNY Return to the list of instruments #AUPH

Currency converter

Amgen Inc.
391.42 USD
09 Sep 2026 21:59
Zmena ceny (% chg)
$0.02
(0.01%)
Prechádzajúca uzatváracia cena
Prechádzajúca uzatváracia cena

Uzatváracia cena predchádzajúceho dňa.
$395.36
Otváracia cena
Otváracia cena

Cena na ktorej otvoril daný deň.
$436.9
Denné maximum
Denné maximum

Najvyššia cena počas posledného obchodného dňa.
$395.36
Denné minimum
Denné minimum

Najnižšia cena počas posledného obchodného dňa
$389.23
Trhová kapitálizácia
Trhová kapitálizácia

Celková hodnota spoločnosti na akciovom trhu. Vo všeobecnosti sa vypočíta ako násobok počtu akcií v obehu a aktuálnej ceny za jednu akciu.
$437.3
Akcie v obehu
Akcie v obehu

Počet akcií držaných investormi a majiteľmi spoločnosti, okrem tzv. rozrieďujúcich cenných papierov ako sú neodňateľné RSU a neuplatnené opcie.
$389.23
Download archive
Buy
391.82
Sell
391.42
Open the chart in full screen view
Buy
391.82
Sell
391.42
Download archive
Open the chart in full screen view

About Amgen Inc.

Amgen Inc. is one of the world's leading biotechnology companies. Founded in 1980 in the United States, it currently operates in more than 70 countries around the world.

Amgen focuses on developing cutting-edge medicines against cancer, cardiovascular diseases, bone ailments, kidney diseases and other afflictions.

The company currently has a market capitalization of $122.5 billion. Amgen reported revenues of $25.98 billion and a net income of $5.89 billion in 2021.

Amgen Inc. stock and what affects it

The company stock is listed on the NASDAQ exchange under the ticker name AMGN. When the company had its initial public offering in 1983, its shares were priced between $16 and $19 at the time.

Now, Amgen's shares are trading between $227 and $231. Last year, it fluctuated from $198 to $258. Forecasts suggest the stock will continue to climb.

When trading this asset, you have to keep the following things in mind:

  • The company has a dominant position in the market.
  • There are potential opportunities to capitalize on its products and strategic initiatives.
  • Threats to Amgen include its competition, government regulation, and the company’s dependence on wholesale distributors.

Can't speak right now?
Ask your question in the chat.